Middle East & Africa Lung Cancer Screening Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 – Regional Analysis – by Cancer Type [Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer], Technology [Low-Dose Computed Tomography (LDCT), Chest X-Ray, Liquid Biopsy, and Others], Age Group (50 & Older and Below 50), and End User (Hospitals, Diagnostic Centers, and Others)

No. of Pages: 100    |    Report Code: BMIRE00029063    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Lung Cancer Screening Market

1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Lung Cancer Screening Market – by Technology

1.3.2        Middle East & Africa Lung Cancer Screening Market – by Cancer Type

1.3.3        Middle East & Africa Lung Cancer Screening Market – by Age Group

1.3.4        Middle East & Africa Lung Cancer Screening Market – by End User

1.3.5        Middle East & Africa Lung Cancer Screening Market – by Country

2.           Middle East & Africa Lung Cancer Screening Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Lung Cancer Screening Market – Market Landscape

4.1         Overview

4.2         Middle East & Africa PEST Analysis

4.3         Expert’s Opinion

5.           Middle East & Africa Lung Cancer Screening Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Lung Cancer Incidences

5.2         Market Restraints

5.2.1        Lack of Awareness regarding the Lung Cancer Screening:

5.3         Market Opportunities

5.3.1        Collaboration with Regional Hospitals and Clinics

5.4         Future Trends

5.4.1        Use of Cutting-Edge Technologies

5.5         Impact Analysis

6.           Lung Cancer Screening Market – Middle East & Africa Market Analysis

6.1         Middle East & Africa Lung Cancer Screening Market Revenue Forecast and Analysis

7.           Middle East & Africa Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type

7.1         Overview

7.2         Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

7.3         Non–Small Cell Lung Cancer (NSCLC)

7.3.1        Overview

7.3.2        Non–Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)

7.4         Small Cell Lung Cancer

7.4.1        Overview

7.4.2        Small Cell Lung Cancer: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.           Middle East & Africa Lung Cancer Screening Market Analysis – by Technology

8.1         Overview

8.2         Low-Dose Computed Tomography (LDCT)

8.2.1        Overview

8.2.2        Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.3         Chest X-ray

8.3.1        Overview

8.3.2        Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.4         Liquid Biopsy

8.4.1        Overview

8.4.2        Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

9.           Middle East & Africa Lung Cancer Screening Market Analysis – by Age Group

9.1         Overview

9.2 & Older

9.2.1        Overview

9.2.2 & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

9.3         Below 50

9.3.1        Overview

9.3.2        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.        Middle East & Africa Lung Cancer Screening Market Analysis – by End User

10.1      Overview

10.2      Hospitals

10.2.1     Overview

10.2.2     Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.3      Diagnostic Centers

10.3.1     Overview

10.3.2     Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.4      Others

10.4.1     Overview

10.4.2     Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

11.        Middle East & Africa Lung Cancer Screening Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Overview

11.1.1     Middle East & Africa: Lung Cancer Screening Market, by Key Country, 2020-2030 (%)

11.1.1.1       South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.3       South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.1.4       South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)

11.1.1.1.5       South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.1.6       South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.2       Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.3       Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.2.4       Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)

11.1.1.2.5       Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.2.6       Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.3       UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.3       UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.3.4       UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)

11.1.1.3.5       UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.3.6       UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.4       Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.3       Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.4.4       Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)

11.1.1.4.5       Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.4.6       Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12.        Lung Cancer Screening Market–Industry Landscape

12.1      Recent Growth Strategies

12.1.1     Overview

13.        Company Profiles

13.1      Nuance Communications Inc

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GE HealthCare

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Medtronic

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Canon Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Koninklijke Philips NV

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Siemens AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             South Africa Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)

Table 2.             South Africa Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 3.             South Africa Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 4.             South Africa Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 5.             Saudi Arabia Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)

Table 6.             Saudi Arabia Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 7.             Saudi Arabia Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Saudi Arabia Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 9.             UAE Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)

Table 10.          UAE Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 11.          UAE Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 12.          UAE Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Rest of Middle East & Africa Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)

Table 14.          Rest of Middle East & Africa Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 15.          Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 16.          Rest of Middle East & Africa Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 17.          Recent Growth Strategies in the Lung Cancer Screening Market

Table 18.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Middle East & Africa Lung Cancer Screening Market Segmentation

Figure 2.           Middle East & Africa Lung Cancer Screening Market, by Country

Figure 3.           Middle East & Africa Lung Cancer Screening Market Overview

Figure 4.           Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Middle East & Africa Lung Cancer  Screening Market

Figure 5.           Middle East & Africa Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Middle East & Africa: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Lung Cancer Screening Market Impact Analysis of Driver and Restraints

Figure 9.           Middle East & Africa Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030

Figure 10.        Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

Figure 11.        Non–Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Small Cell Lung Cancer: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)

Figure 14.        Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)

Figure 19. & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Lung Cancer Screening Market, by End User, 2022 & 2030 (%)

Figure 22.        Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Middle East & Africa: Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)

Figure 26.        Middle East & Africa: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)

Figure 27.        South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28.        Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

The List of Companies - Middle East & Africa Lung Cancer Screening Market

  1. Nuance Communications Inc
  2. GE HealthCare Technologies Inc
  3. Medtronic Plc
  4. Canon Medical Systems Corp
  5. Koninklijke Philips NV
  6. Siemens AG